LYRA Lyra Therapeutics, Inc.
Fundamentals / CIK 0001327273 / USDLyra Therapeutics, Inc. reported $398K in revenue and a net loss of $28.92M for the fiscal year ended December 31, 2025 (down 74.1% year over year), with a -7794.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LYRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$398K -74.1% YoY
-
Operating Income FY 2025-$31.02M -7794.5% margin
-
Net Income FY 2025-$28.92M -7266.1% net margin
-
Diluted EPS FY 2025-$18.62 Split-adjusted
-
Free Cash Flow FY 2025-$28.98M -7280.2% FCF margin
-
Cash & ST Investments Dec 31, 2025$15.89M Total debt: $30.26M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $398K | $1.53M | $1.56M | $1.36M | $285K | -- | -- |
| Research & Development | $18.41M | $43.77M | $48.03M | $38.80M | $29.69M | $12.52M | $12.03M |
| Total Operating Expenses | $31.42M | $97.88M | $68.68M | $57.67M | $43.90M | $22.21M | $16.52M |
| Operating Income | -$31.02M | -$96.35M | -$67.12M | -$56.31M | -$43.62M | -$22.21M | -$16.52M |
| EBITDA | -$30.56M | -$95.88M | -$66.84M | -$55.24M | -$42.61M | -$22.11M | -$16.49M |
| Interest Income | $1.13M | $2.95M | $4.50M | $1.04M | $102K | $82K | $213K |
| Income Before Tax | -$28.91M | -$93.40M | -$62.62M | -$55.27M | -$43.51M | -- | -- |
| Income Tax Expense | $11K | $39K | $59K | $13K | $0 | $0 | $0 |
| Net Income | -$28.92M | -$93.44M | -$62.68M | -$55.28M | -$43.51M | -$22.13M | -$16.31M |
| Basic EPS | -$18.62 | -$71.75 | -$63.00 | -$91.50 | -$167.50 | -$129.50 | -$4,111.50 |
| Diluted EPS | -$18.62 | -$71.75 | -$63.00 | -$91.50 | -$167.50 | -$129.50 | -$4,111.50 |
| Basic Shares Outstanding | 1.6M | 1.3M | 996.1K | 604.7K | 259.7K | 171.8K | 4.0K |
| Diluted Shares Outstanding | 1.6M | 1.3M | 996.1K | 604.7K | 259.7K | 171.8K | 4.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.0K | $25K | $183K | $183K | $209K | $195K | $598K | $532K |
| Research & Development | $4.38M | $4.05M | $5.11M | $4.88M | $6.36M | $5.90M | $13.26M | $18.24M |
| Total Operating Expenses | $7.12M | $6.26M | $9.01M | $9.02M | $11.62M | $12.64M | $49.57M | $24.06M |
| Operating Income | -$7.12M | -$6.24M | -$8.83M | -$8.84M | -$11.41M | -$12.44M | -$48.97M | -$23.52M |
| EBITDA | -$7.02M | -$6.14M | -$8.63M | -$8.71M | -$11.26M | -$12.40M | -$48.77M | -$23.39M |
| Interest Income | $169K | $256K | $410K | $298K | $435K | $576K | $855K | $1.09M |
| Income Before Tax | -$6.95M | -$5.98M | -$7.43M | -$8.54M | -$10.97M | -$11.87M | -$48.12M | -$22.44M |
| Income Tax Expense | $2.0K | $3.0K | $2.0K | $4.0K | $6.0K | $7.0K | $12K | $14K |
| Net Income | -$6.95M | -$5.98M | -$7.44M | -$8.55M | -$10.98M | -$11.87M | -$48.13M | -$22.45M |
| Basic EPS | -- | -$3.38 | -$5.51 | -$6.50 | -- | -$9.07 | -$36.76 | -$17.50 |
| Diluted EPS | -- | -$3.38 | -$5.51 | -$6.50 | -- | -$9.07 | -$36.76 | -$17.50 |
| Basic Shares Outstanding | -- | 1.8M | 1.3M | 1.3M | -- | 1.3M | 1.3M | 1.3M |
| Diluted Shares Outstanding | -- | 1.8M | 1.3M | 1.3M | -- | 1.3M | 1.3M | 1.3M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.89M | $40.58M | $22.35M | $32.55M | $45.75M | $74.59M | $9.81M |
| Short-Term Investments | $0 | $0 | $80.40M | $65.34M | $0 | -- | -- |
| Cash & Short-Term Investments | $15.89M | $40.58M | $102.8M | $97.89M | $45.75M | $74.59M | $9.81M |
| Total Current Assets | $16.27M | $43.02M | $104.8M | $100.8M | $47.92M | $75.92M | $10.12M |
| Property, Plant & Equipment, Net | $1.05M | $1.40M | $2.04M | $2.24M | $4.50M | $2.17M | $237K |
| Other Non-Current Assets | -- | $0 | $1.11M | $3.28M | $762K | $118K | $1.10M |
| Total Non-Current Assets | $19.84M | $23.32M | $37.78M | $9.14M | $6.95M | $4.91M | $4.84M |
| Total Assets | $36.11M | $66.35M | $142.6M | $110.0M | $54.87M | $80.83M | $14.96M |
| Accounts Payable | $663K | $1.18M | $3.13M | $2.62M | $3.12M | $922K | $1.07M |
| Deferred Revenue (Current) | -- | $398K | $1.66M | $1.27M | $9.79M | -- | -- |
| Other Current Liabilities | $518K | $475K | $1.23M | $659K | $633K | $149K | $110K |
| Total Current Liabilities | $9.52M | $12.63M | $19.60M | $14.47M | $18.25M | $4.88M | $5.21M |
| Deferred Revenue (Non-Current) | $11.86M | $11.86M | $12.14M | $14.08M | $1.93M | -- | -- |
| Total Non-Current Liabilities | $37.30M | $42.12M | $33.58M | $14.74M | $2.31M | $1.45M | $2.43M |
| Total Liabilities | $46.83M | $54.75M | $53.18M | $29.21M | $20.55M | $6.34M | $7.63M |
| Total Debt (incl. Leases) | $30.26M | $34.38M | $26.88M | $2.22M | $1.45M | $2.44M | $3.33M |
| Common Stock | $2.0K | $1.0K | $57K | $32K | $13K | $13K | -- |
| Retained Earnings | -$433.7M | -$404.8M | -$311.4M | -$248.7M | -$193.4M | -$149.9M | -$127.8M |
| Accumulated Other Comp. Income | -- | $0 | $33K | $10K | -- | -- | -- |
| Total Stockholders' Equity | -$10.72M | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | -$123.3M |
| Total Equity | -$10.72M | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | -$123.3M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.89M | $22.05M | $29.78M | $31.73M | $40.58M | $23.80M | $31.91M | $15.80M |
| Short-Term Investments | $0 | -- | -- | -- | $0 | $27.83M | $35.59M | $71.32M |
| Cash & Short-Term Investments | $15.89M | $22.05M | $29.78M | $31.73M | $40.58M | $51.63M | $67.50M | $87.12M |
| Total Current Assets | $16.27M | $23.02M | $31.06M | $33.91M | $43.02M | $54.44M | $69.44M | $89.44M |
| Property, Plant & Equipment, Net | $1.05M | $1.12M | $1.16M | $1.28M | $1.40M | $1.61M | $1.67M | $3.78M |
| Other Non-Current Assets | -- | -- | -- | -- | $0 | -- | -- | $683K |
| Total Non-Current Assets | $19.84M | $20.69M | $21.51M | $22.41M | $23.32M | $24.31M | $25.15M | $52.08M |
| Total Assets | $36.11M | $43.71M | $52.57M | $56.32M | $66.35M | $78.76M | $94.58M | $141.5M |
| Accounts Payable | $663K | $627K | $680K | $725K | $1.18M | $2.29M | $4.97M | $2.84M |
| Deferred Revenue (Current) | -- | $7.0K | $32K | $216K | $398K | $607K | $814K | $1.32M |
| Other Current Liabilities | $518K | -- | -- | -- | $475K | -- | -- | -- |
| Total Current Liabilities | $9.52M | $9.48M | $11.16M | $11.47M | $12.63M | $14.95M | $19.28M | $18.72M |
| Deferred Revenue (Non-Current) | $11.86M | $11.86M | $11.86M | $11.86M | $11.86M | $11.86M | $11.85M | $11.94M |
| Total Non-Current Liabilities | $37.30M | $38.56M | $39.79M | $40.97M | $42.12M | $43.18M | $44.33M | $45.30M |
| Total Liabilities | $46.83M | $48.04M | $50.95M | $52.44M | $54.75M | $58.14M | $63.60M | $64.02M |
| Total Debt (incl. Leases) | $30.26M | $31.38M | $32.48M | $33.36M | $34.38M | $35.32M | $36.75M | $37.86M |
| Common Stock | $2.0K | $2.0K | $2.0K | $66K | $1.0K | $65K | $65K | $61K |
| Retained Earnings | -$433.7M | -$426.8M | -$420.8M | -$413.3M | -$404.8M | -$393.8M | -$381.9M | -$333.8M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | $20K | -$4.0K | $25K |
| Total Stockholders' Equity | -$10.72M | -$4.33M | $1.62M | $3.87M | $11.59M | $20.62M | $30.98M | $77.50M |
| Total Equity | -$10.72M | -$4.33M | $1.62M | $3.87M | $11.59M | $20.62M | $30.98M | $77.50M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$28.92M | -$93.44M | -$62.68M | -$55.28M | -$43.51M | -$22.13M | -$16.31M |
| Depreciation & Amortization | $459K | $471K | $278K | $1.07M | $1.00M | $95K | $27K |
| Stock-Based Compensation | $2.33M | $6.72M | $5.89M | $5.45M | $2.77M | $1.81M | $244K |
| Change in Payables | -$516K | -$1.89M | $450K | -$2.41M | $2.35M | $345K | -$205K |
| Operating Cash Flow | -$28.86M | -$70.01M | -$63.30M | -$43.38M | -$25.82M | -$21.14M | -$13.75M |
| Capital Expenditure | -$116K | -$2.34M | -$1.05M | -$164K | -$3.38M | -$1.77M | -$211K |
| Free Cash Flow | -$28.98M | -$72.35M | -$64.35M | -$43.55M | -$29.20M | -$22.92M | -$13.96M |
| Purchases of Investments | -- | -$47.95M | -$122.4M | -$64.84M | -- | -- | -- |
| Investing Cash Flow | -$98K | $80.31M | -$12.58M | -$65.01M | -$3.38M | -$1.77M | -$211K |
| Financing Cash Flow | $4.27M | $8.53M | $65.69M | $96.26M | $359K | $87.70M | -$115K |
| Net Change in Cash | -$24.68M | $18.82M | -$10.20M | -$12.13M | -$28.85M | $64.78M | -$14.08M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.95M | -$5.98M | -$7.44M | -$8.55M | -$10.98M | -$11.87M | -$48.13M | -$22.45M |
| Depreciation & Amortization | $100K | $100K | $200K | $128K | $151K | $39K | $200K | $136K |
| Stock-Based Compensation | $562K | $34K | $914K | $825K | $1.94M | $1.49M | $1.12M | $2.16M |
| Change in Payables | $103K | -$120K | -$45K | -$454K | -$1.11M | -$2.59M | $2.38M | -$560K |
| Operating Cash Flow | -$6.07M | -$7.36M | -$6.59M | -$8.84M | -$11.35M | -$16.22M | -$19.98M | -$22.45M |
| Capital Expenditure | -- | -- | -- | -- | $58K | -$51K | -$196K | -$2.15M |
| Free Cash Flow | -- | -- | -- | -- | -$11.29M | -$16.27M | -$20.18M | -$24.60M |
| Purchases of Investments | -- | -- | -- | -- | $0 | -$12.81M | -$14.62M | -$20.52M |
| Investing Cash Flow | -- | -- | -- | -- | $28.13M | $8.14M | $36.18M | $7.86M |
| Financing Cash Flow | -- | -- | -- | -- | -$1.0K | -$23K | -$89K | $8.64M |
| Net Change in Cash | -$6.16M | -$7.73M | -$1.95M | -$8.84M | $16.78M | -$8.11M | $16.11M | -$5.95M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -7794.5% | -6280.8% | -4308.1% | -4131.0% | -15303.5% | -- | -- |
| Net Profit Margin | -7266.1% | -6090.9% | -4023.1% | -4055.6% | -15267.7% | -- | -- |
| Return on Equity (ROE) | -- | -805.9% | -70.1% | -68.5% | -126.8% | -29.7% | -- |
| Return on Assets (ROA) | -80.1% | -140.8% | -44.0% | -50.3% | -79.3% | -27.4% | -109.0% |
| Current Ratio | 1.71x | 3.41x | 5.35x | 6.97x | 2.63x | 15.54x | 1.94x |
| Quick Ratio | 1.67x | 3.21x | 5.24x | 6.77x | 2.51x | 15.27x | 1.88x |
| Debt to Equity | -- | 2.97x | 0.30x | 0.03x | 0.04x | 0.03x | -- |
| Revenue Growth (YoY) | -74.1% | -1.5% | +14.3% | +378.2% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7794.5% | -5885.3% | -5391.8% | -6891.6% | -6280.8% | -6894.4% | -5813.3% | -4364.9% |
| Net Profit Margin | -7266.1% | -5491.2% | -5043.6% | -6711.4% | -6090.9% | -6635.8% | -5570.9% | -4099.8% |
| Return on Equity (ROE) | -- | -- | -2394.3% | -2054.0% | -805.9% | -473.4% | -327.3% | -88.9% |
| Return on Assets (ROA) | -80.1% | -75.4% | -73.9% | -141.2% | -140.8% | -123.9% | -107.2% | -48.7% |
| Current Ratio | 1.71x | 2.43x | 2.78x | 2.96x | 3.41x | 3.64x | 3.60x | 4.78x |
| Quick Ratio | 1.67x | 2.33x | 2.67x | 2.77x | 3.21x | 3.45x | 3.50x | 4.65x |
| Debt to Equity | -- | -- | 20.02x | 8.61x | 2.97x | 1.71x | 1.19x | 0.49x |
| Revenue Growth (YoY) | -96.7% | -87.2% | -69.4% | -65.6% | +43.2% | -64.2% | +30.6% | +29.8% |